INNATE PHARMA
Last · Paris€1.294+0.03 (+2.37%)live · yahoo · 2h ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume145.6Ksession
| Revenue | €20.1M |
|---|---|
| Operating income | €-51.6M |
| Net income | €-49.5M |
| Free cash flow | €-7.3M |
| Operating margin | -256.3% |
| Net margin | -245.9% |
| Return on equity | -560.0% |
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-04-01
- Operating Cf Burn
- Net Margin Sharply Negative
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -546.1%
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
2.3M
Earnings transcripts
Documents
FormReporting forFiledFlags